M. Sons Herbal Daily Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 06-12-2024
- Paid Up Capital ₹ 0.10 M
as on 06-12-2024
- Company Age 8 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue -2.09%
(FY 2022)
- Profit 21.42%
(FY 2022)
- Ebitda -3.59%
(FY 2022)
- Net Worth 42.87%
(FY 2022)
- Total Assets 25.12%
(FY 2022)
About M. Sons Herbal Daily
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ashok Mehta, Kiran Mehta, and Manju Pitiliya serve as directors at the Company.
- CIN/LLPIN
U74999RJ2016PLC056501
- Company No.
056501
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
09 Dec 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Udaipur, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does M. Sons Herbal Daily Limited offer?
M. Sons Herbal Daily Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Nutraceuticals & Dietary Supplements, Weight Loss Supplement, Herbal Capsules, Digestive System Drugs & Medicines, Digestive Drugs, Medical Consultants & Clinics, Skin Treatment Solution, Liver Supplement.
Who are the key members and board of directors at M. Sons Herbal Daily?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Mehta  | Director | 09-Dec-2016 | Current |
| Kiran Mehta | Director | 09-Dec-2016 | Current |
| Manju Pitiliya | Director | 01-May-2019 | Current |
Financial Performance of M. Sons Herbal Daily.
M. Sons Herbal Daily Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 2.09% decrease. The company also saw a substantial improvement in profitability, with a 21.42% increase in profit. The company's net worth Soared by an impressive increase of 42.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of M. Sons Herbal Daily?
In 2022, M. Sons Herbal Daily had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Raytech Consultancy Services Private LimitedActive 27 years 9 monthsAshok Mehta and Kiran Mehta are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at M. Sons Herbal Daily?
Unlock and access historical data on people associated with M. Sons Herbal Daily, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of M. Sons Herbal Daily, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped M. Sons Herbal Daily's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
